- Enter urine K⁺, serum K⁺, urine osmolality, and serum osmolality from concurrent samples.
- Select the patient's potassium status (hyperkalemia or hypokalemia) — this determines the interpretation thresholds.
- If urine osmolality < serum osmolality, the result is displayed but flagged as unreliable (validity criterion not met).
- Interpret the TTKG in conjunction with urine Na, aldosterone levels, and the full clinical picture — do not act on the TTKG alone.
All computation runs in your browser; no values are stored or transmitted.
When to Use
Use the TTKG to assess the activity of aldosterone on the cortical collecting duct — the main site of potassium secretion under hormonal regulation. By correcting urine K⁺ for the osmotic concentration that occurs between the cortical collecting duct and the final urine, the TTKG estimates the K⁺ concentration that would have left the collecting duct, providing a window into aldosterone-mediated K⁺ secretion.
Appropriate setting
Adults with documented hyperkalemia (K⁺ > 5.0 mEq/L) in whom you suspect impaired renal K⁺ excretion (hypoaldosteronism, aldosterone resistance, type 4 RTA), or documented hypokalemia (K⁺ < 3.5 mEq/L) in whom you need to distinguish renal wasting from non-renal causes. Best used as an adjunct to urine K⁺:Cr ratio and clinical context — not as a standalone diagnostic.
Validity requirement: U_osm ≥ S_osm
TTKG is only interpretable when urine osmolality ≥ serum osmolality. This ensures that ADH is acting (tubular fluid is being concentrated), a prerequisite for the underlying physiologic assumption — that fluid leaving the cortical collecting duct has an osmolality equal to that of plasma. If urine is dilute (U_osm < S_osm), ADH effect is absent and the correction is invalid. Also confirm urine Na > 25 mEq/L before interpreting.
Pearls & Pitfalls
Hyperkalemia: TTKG ≤ 7 suggests impaired K excretion
In a patient with hyperkalemia, an appropriate renal response is a TTKG > 7 (often > 10), reflecting high aldosterone-driven K⁺ secretion in the cortical collecting duct. A TTKG ≤ 7 in the context of hyperkalemia is inappropriately low and suggests aldosterone deficiency (type 4 RTA, Addison's disease, ACE-I/ARB effect, heparin) or aldosterone resistance (pseudohypoaldosteronism, spironolactone, amiloride, trimethoprim, tacrolimus, CKD).
Hypokalemia: TTKG > 4 suggests renal K wasting
In hypokalemia, a TTKG < 3 is appropriate (the kidney is conserving K⁺). A TTKG > 4 in hypokalemia indicates that the kidney is excreting too much potassium — pointing to primary or secondary hyperaldosteronism, Bartter/Gitelman syndrome, loop or thiazide diuretics, or Cushing's syndrome. A TTKG of 3–4 in hypokalemia is indeterminate.
Critical limitations — use as an adjunct only
(1) Theoretical assumptions challenged: The TTKG's derivation assumes negligible K⁺ recycling in the medullary collecting duct and no K⁺ reabsorption distal to the cortex — assumptions shown to be physiologically imprecise. (2) Urine dilution invalidates the result — U_osm must be ≥ S_osm. (3) Urine Na < 25 mEq/L limits Na delivery to the collecting duct and reduces K⁺ secretion independent of aldosterone. (4) Some guidelines prefer the urine K⁺:creatinine ratio or 24-hour urine K⁺ as more reliable alternatives for assessing renal K⁺ excretion. Use TTKG as a quick bedside adjunct, not as a definitive test.
Why Use It
Serum and urine potassium levels alone cannot answer whether hyperkalemia is caused by impaired renal excretion or by excessive intake/redistribution. The TTKG attempts to isolate the collecting duct's K⁺ handling from the confounding effect of medullary concentration by dividing urine K⁺ by the osmolal concentration ratio (U_osm/S_osm). A high TTKG in hyperkalemia means the kidney is trying to excrete K⁺ but cannot overcome a large load — pointing to dietary, redistribution, or tissue-release causes. A low TTKG in hyperkalemia means the kidney itself is the problem — reduced aldosterone action. This distinction shapes the next diagnostic and therapeutic step: aldosterone replacement, fludrocortisone challenge, potassium binders, or dietary counseling. In hypokalemia, distinguishing renal from non-renal (GI/sweat) K⁺ loss similarly focuses the workup and guides treatment.
TTKG — Transtubular Potassium Gradient Calculator
Enter concurrent urine and serum potassium and osmolality, and select the potassium disorder being investigated. A validity warning is shown if U_osm < S_osm.
⚕ TTKG = (U_K × S_osm) / (S_K × U_osm). Valid only when U_osm ≥ S_osm and urine Na > 25 mEq/L. Use as an adjunct — the TTKG's physiologic assumptions have been challenged and clinical context is essential. Physician interpretation required.
Next Steps
Integrate the TTKG with urine K⁺/Cr ratio, serum aldosterone, and renin for a complete evaluation.
- Hyperkalemia + TTKG ≤ 7 (impaired excretion): Assess the aldosterone axis — plasma renin activity (PRA) and serum aldosterone. Low renin + low aldosterone = hyporeninemic hypoaldosteronism (classic type 4 RTA, common in diabetic nephropathy, CKD). Low renin + high aldosterone = uncommon. High renin + low aldosterone = adrenal insufficiency (Addison's). High renin + high aldosterone + low TTKG = aldosterone resistance (pseudohypoaldosteronism, blocking drugs — review spironolactone, amiloride, trimethoprim, tacrolimus).
- Hyperkalemia + TTKG > 7 (appropriate excretion): The kidney is responding to hyperkalemia — investigate excessive K⁺ intake, redistribution (acidosis, insulin deficiency, beta-blockade), or cellular release (rhabdomyolysis, hemolysis, tumor lysis).
- Hypokalemia + TTKG > 4 (renal wasting): Evaluate for primary hyperaldosteronism (Conn's syndrome), secondary hyperaldosteronism (renovascular hypertension, CHF, cirrhosis), diuretic use (loop, thiazide), Bartter/Gitelman syndrome, Cushing's syndrome, or excess licorice intake.
- Hypokalemia + TTKG < 3 (appropriate K conservation): Investigate GI losses (diarrhea, vomiting, nasogastric suction), inadequate dietary K⁺, or transcellular shift (insulin, alkalosis, beta-agonists).
- Refer to nephrology for persistent unexplained dyskalemia, or when the RAAS axis evaluation is complex.
Evidence & References
Formula
| Quantity | Equation |
|---|---|
| TTKG (unitless) | (U_K × S_osm) / (S_K × U_osm) |
| Validity criterion | U_osm ≥ S_osm AND urine Na > 25 mEq/L |
| Hyperkalemia — appropriate response | TTKG > 7 (suggests adequate aldosterone-mediated K⁺ excretion) |
| Hyperkalemia — impaired excretion | TTKG ≤ 7 (suggests hypoaldosteronism or aldosterone resistance) |
| Hypokalemia — renal K wasting | TTKG > 4 (suggests inappropriate K⁺ excretion) |
| Hypokalemia — appropriate conservation | TTKG < 3 (suggests non-renal K⁺ loss) |
References
- West ML, Marsden PA, Richardson RMA, Zettle RM, Halperin ML. New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab. 1986;12(4):234–238.
- Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19(3):424–426.
- Ethier JH, Kamel KS, Magner PO, Lemann J Jr, Halperin ML. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis. 1990;15(4):309–315.
